| NDC Code | 58048-0004-1 |
|---|
| Package Description | 60 mL in 1 BOTTLE, DROPPER (58048-0004-1) |
|---|
| Product NDC | 58048-0004 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Lyme And Co-infection Nosode |
|---|
| Non-Proprietary Name | Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Chlamydia Trachomatis, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Prowazekii, Encephalitis Nosode, Ledum Palustre |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190129 |
|---|
| End Marketing Date | 20240307 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Bhp Holdings, Inc. |
|---|
| Substance Name | ANGELICA ARCHANGELICA ROOT; ANHYDROUS CITRIC ACID; ARNICA MONTANA; BABESIA MICROTI; BORRELIA BURGDORFERI; CAUSTICUM; CHLAMYDIA TRACHOMATIS; GOLDENSEAL; HUMAN HERPESVIRUS 5; JAPANESE ENCEPHALITIS VIRUS; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RICKETTSIA PROWAZEKII; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; YUCCA FILAMENTOSA |
|---|
| Strength | 2; 6; 8; 12; 12; 6; 12; 5; 6; 12; 12; 30; 8; 8; 8; 4; 3; 8; 3; 6; 3 |
|---|
| Strength Unit | [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|